PL2267025T3 - Oczyszczanie fibrynogenu - Google Patents

Oczyszczanie fibrynogenu

Info

Publication number
PL2267025T3
PL2267025T3 PL10183940T PL10183940T PL2267025T3 PL 2267025 T3 PL2267025 T3 PL 2267025T3 PL 10183940 T PL10183940 T PL 10183940T PL 10183940 T PL10183940 T PL 10183940T PL 2267025 T3 PL2267025 T3 PL 2267025T3
Authority
PL
Poland
Prior art keywords
fibrinogen
purification
negative
gel
vulnerary
Prior art date
Application number
PL10183940T
Other languages
English (en)
Inventor
Annette Feussner
Volker Gawantka
Jörg Lemmer
Uwe Liebing
Hubert Metzner
Stefan Schulte
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of PL2267025T3 publication Critical patent/PL2267025T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C3/00—Dental tools or instruments
    • A61C3/06—Tooth grinding or polishing discs; Holders therefor
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B15/00—Other brushes; Brushes with additional arrangements
    • A46B15/0002—Arrangements for enhancing monitoring or controlling the brushing process
    • A46B15/0016—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means
    • A46B15/0032—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means with protrusion for polishing teeth
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B7/00—Bristle carriers arranged in the brush body
    • A46B7/04—Bristle carriers arranged in the brush body interchangeably removable bristle carriers
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B9/00—Arrangements of the bristles in the brush body
    • A46B9/02—Position or arrangement of bristles in relation to surface of the brush body, e.g. inclined, in rows, in groups
    • A46B9/04—Arranged like in or for toothbrushes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B2200/00—Brushes characterized by their functions, uses or applications
    • A46B2200/10—For human or animal care
    • A46B2200/1066—Toothbrush for cleaning the teeth or dentures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL10183940T 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu PL2267025T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004009400A DE102004009400A1 (de) 2004-02-24 2004-02-24 Fibrinogen Reinigung
EP20100183940 EP2267025B1 (de) 2004-02-24 2005-02-12 Reinigung von Fibrinogen
EP05003017A EP1568709B1 (de) 2004-02-24 2005-02-12 Reinigung von Fibrinogen

Publications (1)

Publication Number Publication Date
PL2267025T3 true PL2267025T3 (pl) 2015-10-30

Family

ID=34745287

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10183940T PL2267025T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu
PL05003017T PL1568709T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05003017T PL1568709T3 (pl) 2004-02-24 2005-02-12 Oczyszczanie fibrynogenu

Country Status (11)

Country Link
US (1) US7550567B2 (pl)
EP (3) EP2264069B1 (pl)
JP (2) JP4965805B2 (pl)
KR (1) KR101195777B1 (pl)
AT (1) ATE509030T1 (pl)
AU (1) AU2005200635B2 (pl)
CA (1) CA2497796C (pl)
DE (1) DE102004009400A1 (pl)
DK (3) DK2267025T3 (pl)
ES (3) ES2365241T3 (pl)
PL (2) PL2267025T3 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887883B1 (fr) * 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
EP1950225A1 (de) * 2007-01-25 2008-07-30 Octapharma AG Verfahren zur Steigerung von Proteinausbeuten
US8367412B2 (en) * 2007-02-23 2013-02-05 Kwansei Gakuin Educational Foundation Protein crystallizing agent and method of crystallizing protein therewith
EP2130549B1 (en) * 2007-03-22 2014-07-16 The Chemo-Sero-Therapeutic Research Institute Solid fibrinogen preparation
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
HUE028626T2 (en) 2008-06-23 2016-12-28 Bio-Products & Bio-Engineering Ag Stable, functionally intact, virus-inactivated fibrinogen during storage
WO2010042741A1 (en) * 2008-10-08 2010-04-15 Thrombodyne, Inc. Methods of making concentrated fibrinogen- and platelet containing compositions
US8314211B2 (en) * 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
IL213864A0 (en) * 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
ES2642383T3 (es) 2012-03-13 2017-11-16 Octapharma Ag Procedimiento mejorado de producción de fibrinógeno y fibrinógeno producido por el mismo
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
CN104148037A (zh) * 2014-08-08 2014-11-19 华东理工大学 一种精氨酸键合型亲水色谱固定相及制备方法
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
KR101841587B1 (ko) * 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
AU2017235870B2 (en) 2016-03-17 2023-02-23 Perkinelmer Health Sciences B.V. Detection of cells in a liquid sample
US20190316133A1 (en) * 2016-07-06 2019-10-17 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Anti-Fibrinogen Aptamers and Uses Thereof
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
IL265102B2 (en) 2016-09-01 2023-11-01 Plas Free Ltd Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders
JP2018168082A (ja) * 2017-03-29 2018-11-01 フジッコ株式会社 皮膚修復機能促進用組成物
EP3556728A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Organically modified mineral micro-particles, methods of preparing the same and uses thereof
US20230022328A1 (en) 2019-12-10 2023-01-26 Biotest Ag Method for Manufacturing a Fibrinogen Preparation
CN111848783B (zh) * 2020-07-29 2023-07-04 同路生物制药有限公司 一种人纤维蛋白原的制备方法
AU2022426762A1 (en) 2021-12-30 2024-07-04 Baxter Healthcare Sa Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4188318A (en) 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
CA1054052A (en) 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
DE2903131A1 (de) * 1978-02-06 1979-08-09 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophilen globulin a enthaltenden konzentrats neben einem prothrombin-komplex und einer loesung von lagerstabilen serumproteinen
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
US5043428A (en) 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
ATE52425T1 (de) * 1985-02-04 1990-05-15 Hoffmann La Roche Adsorbens fuer die reinigung von proteinen.
DE3734923C1 (de) 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5138034A (en) 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
DE3926539A1 (de) 1989-08-11 1991-02-14 Braun Melsungen Ag Verwendung von tentakel-kationenaustauschern zur selektiven eliminierung von low-density-lipoproteinen (ldl), fibrinogen und/oder harnstoff aus fluessigkeiten
WO1993005067A1 (en) * 1991-09-05 1993-03-18 Baxter International, Inc. Topical fibrinogen complex
FR2686883B1 (fr) 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
US5259971A (en) 1992-03-02 1993-11-09 Cryolife, Inc. Method of preparing fibrinogen
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
CA2162997A1 (en) 1994-03-18 1995-09-28 Daphne C. Tse Topical fibrinogen complex
CA2195127C (en) 1994-07-14 2007-06-19 Ruth Laub Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5723579A (en) 1996-02-02 1998-03-03 Bayer Corporation Fibrinogen binding peptides
US6037457A (en) 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US5876947A (en) 1997-07-25 1999-03-02 The New York Blood Center, Inc. Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
AU749177B2 (en) * 1997-10-23 2002-06-20 Fujimori Kogyo Co. Ltd. Method for purifying thrombin substrates and/or inhibitors or method for eliminating the same
US5783663A (en) 1998-01-23 1998-07-21 Bayer Corporation Peptide ligands for affinity purification of fibrinogen
NZ505424A (en) 1998-01-23 2002-09-27 Csl Ltd Purification of fibrinogen
GB9807464D0 (en) 1998-04-07 1998-06-10 Pharming Bv Purification of human acid µ-glucosidase
DE69930653T2 (de) * 1998-09-24 2007-01-25 Pharming Intellectual Property Bv Reinigung von fibrinogen aus milch durch den einsatz von kationenaustauschchromatographie
DK1115745T3 (da) 1998-09-24 2006-10-02 Pharming Intellectual Pty Bv Oprensning af fibrinogen fra væsker ved udfældning og hydrofob interaktionskromatografi
JP2003511468A (ja) 1999-10-08 2003-03-25 ブイ アイ テクノロジーズ インコーポレイテッド 同種凝集素枯渇血液組成物および同種凝集素枯渇血液組成物の作製方法
HK1047754B (en) 1999-12-23 2009-11-20 Csl Limited Separation of fibrinogen from plasma proteases
HU228899B1 (en) 2001-05-21 2013-06-28 Omrix Biopharm Sa Removal of plasmin(ogen)from protein solutions
IL161262A0 (en) * 2001-10-03 2004-09-27 Christopher J Woolverton Storage-stable human fibrinogen solutions
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition

Also Published As

Publication number Publication date
KR101195777B1 (ko) 2012-11-05
EP1568709A3 (de) 2005-11-02
DK2267025T3 (en) 2015-07-20
JP2005239719A (ja) 2005-09-08
EP1568709B1 (de) 2011-05-11
EP2267025A2 (de) 2010-12-29
JP4965805B2 (ja) 2012-07-04
ES2365241T3 (es) 2011-09-27
AU2005200635B2 (en) 2011-11-10
US20050197493A1 (en) 2005-09-08
EP2264069A2 (de) 2010-12-22
JP5713880B2 (ja) 2015-05-07
EP1568709A2 (de) 2005-08-31
DK1568709T3 (da) 2011-08-22
EP2267025B1 (de) 2015-05-13
US7550567B2 (en) 2009-06-23
ATE509030T1 (de) 2011-05-15
JP2012051947A (ja) 2012-03-15
ES2409888T3 (es) 2013-06-28
CA2497796C (en) 2016-03-29
EP2264069A3 (de) 2011-05-04
KR20060043134A (ko) 2006-05-15
CA2497796A1 (en) 2005-08-24
PL1568709T3 (pl) 2011-09-30
AU2005200635A1 (en) 2005-09-08
DK2264069T3 (da) 2013-07-15
EP2264069B1 (de) 2013-04-17
ES2544456T3 (es) 2015-08-31
DE102004009400A1 (de) 2005-09-08
EP2267025A3 (de) 2011-05-04

Similar Documents

Publication Publication Date Title
PL1568709T3 (pl) Oczyszczanie fibrynogenu
EA201100177A1 (ru) СПОСОБЫ ОЧИСТКИ АНТИТЕЛ К β-АМИЛОИДУ
WO2004024866A3 (en) Protein purification
CR8996A (es) PRODUCCION DE a-BETA
ATE242317T1 (de) Verfahren zur reinigung von viren mit chromatographie
CR8997A (es) Produccion de polipeptidos
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
CA2340863A1 (en) Thrombin preparations and process for their production
AU2016222301A1 (en) Isolation and purification of antibodies using Protein A affinity chromatography
SE7700858L (sv) Vattenolosliga tanninberedningar
GB2337261A8 (en) Purification of nucleic acid from whole cells witha porous membrane filter under pressure
WO2003009926A1 (en) Hollow fiber membrane for purifying blood
RU2013125443A (ru) Активирующее устройство и способ активации для сдвоенной батарейной системы
DE602004023065D1 (de) Verfahren zur Reiningung von Vancomycin-Hydrochlorid
ATE228391T1 (de) Verbesserte membran
CY1107319T1 (el) Μεθοδος για τον καθαρισμο βακτηριακων κυτταρων και κυτταρικων συστατικων
RU2013127275A (ru) СПОСОБ СНИЖЕНИЯ И/ИЛИ УДАЛЕНИЯ FXI И FXIa ИЗ РАСТВОРОВ, СОДЕРЖАЩИХ УКАЗАННЫЕ ФАКТОРЫ СВЕРТЫВАНИЯ
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
MX2023011371A (es) Purificacion de anticuerpos mediante cromatografia de modo mezclado.
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE60006129D1 (de) Verfahren zur reinigung von 2-keto-l-gulonic säure
EA200600102A1 (ru) Очистка вариантов her-2
ATE528393T1 (de) Verfahren zur reinigung von protein und glucosedehydrogenase
ATE468343T1 (de) Verfahren zur reinigung von tacrolimus
WO2024243274A3 (en) Mixed mode subtractive anion exchange chromatography ligands based on 4-(2-(dimethylamino)ethoxy)aniline structures